Novan Inc Stock Fundamentals
| NOVNDelisted Stock | USD 0.03 0.01 33.46% |
Novan Inc fundamentals help investors to digest information that contributes to Novan's financial success or failures. It also enables traders to predict the movement of Novan Stock. The fundamental analysis module provides a way to measure Novan's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Novan stock.
Novan |
Novan Inc Company Return On Equity Analysis
Novan's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Novan Return On Equity | -20.99 |
Most of Novan's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Novan Inc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
CompetitionBased on the latest financial disclosure, Novan Inc has a Return On Equity of -20.9889. This is 12.44% lower than that of the Pharmaceuticals sector and 42.43% lower than that of the Health Care industry. The return on equity for all United States stocks is notably higher than that of the company.
Novan Inc Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Novan's current stock value. Our valuation model uses many indicators to compare Novan value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Novan competition to find correlations between indicators driving Novan's intrinsic value. More Info.Novan Inc is rated below average in return on equity category among related companies. It is rated below average in return on asset category among related companies . Comparative valuation analysis is a catch-all model that can be used if you cannot value Novan by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Novan's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Novan's earnings, one of the primary drivers of an investment's value.Novan Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Novan's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Novan could also be used in its relative valuation, which is a method of valuing Novan by comparing valuation metrics of similar companies.Novan is currently under evaluation in return on equity category among related companies.
Novan Fundamentals
| Return On Equity | -20.99 | |||
| Return On Asset | -0.26 | |||
| Profit Margin | (1.29) % | |||
| Operating Margin | (1.59) % | |||
| Current Valuation | 27.74 M | |||
| Shares Outstanding | 28.02 M | |||
| Shares Owned By Insiders | 0.86 % | |||
| Shares Owned By Institutions | 14.93 % | |||
| Number Of Shares Shorted | 462.95 K | |||
| Price To Earning | (1.49) X | |||
| Price To Book | 5.10 X | |||
| Price To Sales | 2.30 X | |||
| Revenue | 23.61 M | |||
| Gross Profit | 313 K | |||
| EBITDA | (33.76 M) | |||
| Net Income | (31.31 M) | |||
| Cash And Equivalents | 14.9 M | |||
| Cash Per Share | 0.61 X | |||
| Total Debt | 3.93 M | |||
| Debt To Equity | 4.30 % | |||
| Current Ratio | 0.97 X | |||
| Book Value Per Share | (0.10) X | |||
| Cash Flow From Operations | (30.88 M) | |||
| Short Ratio | 0.71 X | |||
| Earnings Per Share | (0.84) X | |||
| Target Price | 15.5 | |||
| Number Of Employees | 90 | |||
| Beta | -0.0434 | |||
| Market Capitalization | 2.64 M | |||
| Total Asset | 90.33 M | |||
| Retained Earnings | (310.28 M) | |||
| Working Capital | (4.03 M) | |||
| Current Asset | 12.51 M | |||
| Current Liabilities | 5.49 M | |||
| Z Score | -5.43 | |||
| Net Asset | 90.33 M |
About Novan Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Novan Inc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Novan using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Novan Inc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Novan, Inc., a medical dermatology company, focuses on researching, developing, and commercializing therapeutic products for skin diseases. Novan, Inc. was incorporated in 2006 and is headquartered in Durham, North Carolina. Novan operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 29 people.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Novan in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Novan's short interest history, or implied volatility extrapolated from Novan options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Other Consideration for investing in Novan Stock
If you are still planning to invest in Novan Inc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Novan's history and understand the potential risks before investing.
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |